RxDoctor Payments Data

Jorge Romo, MD

Anesthesiology · Oak Lawn, ILNPI 1689179301

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (53.1%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Abbott at 36.8% of the total. Reporting peaked in 2023 at $7,139 and has fallen 89.9% since, to $724 in 2025. Among anesthesiology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,128in general payments, 2019–2025

Across 109 payments — averaging $120.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$5K
  • Nevro Corp.$2K
  • Boston Scientific$2K
  • Medtronic$2K
  • Saluda Medical Americas, Inc.$778
  • Stryker$744
  • plus $1K from 4 others

What the payments were for

  • Speaking & faculty fees$1,31910%
  • Travel & lodging$4,83237%
  • Food & beverage$6,97753%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,128 in reported general payments places this provider in the 95th percentile of 1,980 anesthesiology providers in Illinois.

See all anesthesiology providers in Illinois

Medicare billing

Part B allowed, 2024
$54,636
Medicare patients
137
Services billed
483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin129$2,012
Gabapentin172$1,638
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen64$1,092
Tizanidine Hcl32$300
Duloxetine Hcl28$216
Cyclobenzaprine Hcl23$208
Meloxicam42$124
Celecoxib16$107
Tramadol Hcl23$66

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Oak Lawn

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →